|
2003 - Review Articles
Citations 1-10 of 23 total displayed.
|
Most recent content
(1 Dec 2003):
|
- Reviews
Combining trastuzumab (Herceptin®) with hormonal therapy in breast cancer: what can be expected and why?
- A. Jones
Ann. Onc. 2003; 14: 1697-1704.
[Abstract]
[Full text]
[PDF]
- Reviews
The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice
- F. Graziano, B. Humar, and P. Guilford
Ann. Onc. 2003; 14: 1705-1713.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 2003):
|
- Reviews
Antigen- and/or immune-driven lymphoproliferative disorders
- M. D. Aljurf, T. W. Owaidah, A. Ezzat, E. Ibrahim, and A. Tbakhi
Ann. Onc. 2003; 14: 1595-1606.
[Extract]
[Full text]
[PDF]
- Reviews
Progress in the development and acquisition of anticancer agents from marine sources
- M. L. Amador, J. Jimeno, L. Paz-Ares, H. Cortes-Funes, and M. Hidalgo
Ann. Onc. 2003; 14: 1607-1615.
[Extract]
[Full text]
[PDF]
- Reviews
Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness
- M.-F. Yuen and C.-L. Lai
Ann. Onc. 2003; 14: 1463-1467.
[Abstract]
[Full text]
[PDF]
- Reviews
The antineoplastic role of bisphosphonates: from basic research to clinical evidence
- D. Santini, U. Vespasiani Gentilucci, B. Vincenzi, A. Picardi, F. Vasaturo, A. La Cesa, N. Onori, S. Scarpa, and G. Tonini
Ann. Onc. 2003; 14: 1468-1476.
[Abstract]
[Full text]
[PDF]
- Reviews
Hepatitis C and B-cell lymphoma
- N. C. Turner, G. Dusheiko, and A. Jones
Ann. Onc. 2003; 14: 1341-1345.
[Abstract]
[Full text]
[PDF]
- Reviews
The Hsp90 chaperone complex as a novel target for cancer therapy
- M. P. Goetz, D. O. Toft, M. M. Ames, and C. Erlichman
Ann. Onc. 2003; 14: 1169-1176.
[Abstract]
[Full text]
[PDF]
- Reviews
Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors
- M. Renga, P. Pedrazzoli, and S. Siena
Ann. Onc. 2003; 14: 1177-1184.
[Abstract]
[Full text]
[PDF]
- Reviews
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer
- M. Piccart, L. M. Parker, and K. I. Pritchard
Ann. Onc. 2003; 14: 1017-1025.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|